Oncologic breast surgery of retroareolar breast cancer with racquet mammoplasty technique

Oncoplastic breast surgery is increasingly preferred method of intervention today. Surgery allows for the removal of mass with clear borders while keeping the appearance within the acceptable standards. The success of breast conserving surgery is evident only after the radiotherapy received. Oncoplastic techniques that allow filling of the defect by shifting the breast tissue are the best option for the treatment. An invasive ductal carcinoma with dimensions of 23 mm × 21 mm, located in the retroareolar area on the upper outer quadrant of the right breast was detected in a 59-year-old postmenopausal female patient. Taking into the consideration of tumor-breast ratio, localization of tumor, the density of the breast and skin features, racquet mammoplasty technique was used. In today’s world, breast cancer is considered to be a chronic disease by the World Health Organization. In a well-staged condition, the surgical intervention must be applied with an acceptable cosmetic appearance.

PDF

___

1. Pesce CE, Liederbach E, Czechura T, Winchester DJ, Yao K. Changing surgical trends in young patients with early stage breast cancer, 2003 to 2010: A report from the National Cancer Data Base. J Am Coll Surg 2014;219(1):19–28.
2. Laronga C, Lewis JD, Smith PD. The changing face of mastectomy: An oncologic and cosmetic perspective. Cancer Control 2012;19(4):286– 94.
3. Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: A classification and quadrant per quadrant atlas for oncoplastic surgery. Ann Surg Oncol 2010;17(5):1375–91.
4. Rezai M, Knispel S, Kellersmann S, Lax H, Kimmig R, Kern P. Systematization of oncoplastic surgery: Selection of surgical techniques and patient-reported outcome in a cohort of 1,035 patients. Ann Surg Oncol 2015;22(11):3730–7.
5. Habibi M, Broderick KP, Sebai ME, Jacobs LK. Oncoplastic breast reconstruction: Should all patients be considered? Surg Oncol Clin N Am 2018;27(1):167–80.
6. Deutsch M, Land SR, Begovic M, Wieand HS, Wolmark N, Fisher B. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06. Cancer 2003;98(7):1362–8.
7. Christian MC, McCabe MS, Korn EL, Abrams JS, Kaplan RS, Friedman MA. The National Cancer Institute audit of the national surgical adjuvant breast and bowel project protocol B-06. N Engl J Med 1995;333(22):1469–74.
8. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 2010;11(10):927–33.
9. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, et al. Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: A practice-changing trial. Ann Surg Oncol 2011;18(9):2407–12.
10. Morrow M. Margins in breast-conserving therapy: Have we lost sight of the big picture? Expert Rev Anticancer Ther 2008;8(8):1193–6.